Korean J Gastroenterol.  2020 Nov;76(5):242-245. 10.4166/kjg.2020.138.

Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant

• Yang HJ

• KMID: 2508873
• DOI: http://doi.org/10.4166/kjg.2020.138

Abstract

Antiplatelet and anticoagulation agents are increasingly prescribed for secondary prophylaxis in patients with cardiovascular and cerebrovascular diseases. These drugs are associated with an increased risk of gastrointestinal bleeding, including peptic ulcer bleeding. It is difficult to decide when to restart the agents after peptic ulcer bleeding in these patients because the risk of rebleeding and thromboembolism should be balanced. The Korean College of Helicobacter and Upper Gastrointestinal Research revised the guidelines for drug-induced peptic ulcers as evidence-based guidelines using a de novo process. This paper introduces new recommendations on the resumption of antiplatelet and anticoagulation agents after peptic ulcer bleeding based on the revised guidelines for drug-induced peptic ulcers.

Keyword

Peptic ulcer hemorrhage; Aspirin; Platelet aggregation inhibitors; Anticoagulants; Guideline

Reference

1. Kim H, Kim S, Han S, et al. 2019; Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study. BMC Public Health. 19:1112. DOI: 10.1186/s12889-019-7439-0. PMID: 31412823. PMCID: PMC6694551.

2. Chronic disease management. 2019. May. 15. [Internet]. Korea Disease Control and Prevention Agency;Osong (KR): Available from: http://www.cdc.go.kr/contents.es?mid=a20303020300a. updated 2020 Oct 15; cited 2020 Sep 26.

3. Shim YK, Kim N. 2016; Nonsteroidal anti-inflammatory drug and aspirin-induced peptic ulcer disease. Korean J Gastroenterol. 67:300–312. DOI: 10.4166/kjg.2016.67.6.300. PMID: 27312830.

4. García Rodríguez LA, Hernández-Díaz S, de Abajo FJ. 2001; Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol. 52:563–571. DOI: 10.1046/j.0306-5251.2001.01476.x. PMID: 11736865. PMCID: PMC2014603.

5. García Rodríguez LA, Jick H. 1994; Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 343:769–772. DOI: 10.1016/S0140-6736(94)91843-0. PMID: 7907735.

6. Squizzato A, Bellesini M, Takeda A, Middeldorp S, Donadini MP. 2017; Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events. Cochrane Database Syst Rev. 12:CD005158. DOI: 10.1002/14651858.CD005158.pub4. PMID: 29240976. PMCID: PMC6486024.

7. Bhatt DL, Fox KA, Hacke W, et al. 2006; Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 354:1706–1717. DOI: 10.1056/NEJMoa060989. PMID: 16531616.

8. Diener HC, Bogousslavsky J, Brass LM, et al. 2004; Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 364:331–337. DOI: 10.1016/S0140-6736(04)16721-4. PMID: 15276392.

9. Tien A, Kwok K, Dong E, et al. 2020; Impact of direct-acting oral anticoagulants and warfarin on postendoscopic GI bleeding and thromboembolic events in patients undergoing elective endoscopy. Gastrointest Endosc. 92:284–292.e2. DOI: 10.1016/j.gie.2020.02.038. PMID: 32126220.

10. Gu ZC, Wei AH, Zhang C, et al. 2020; Risk of major gastrointestinal bleeding with new vs conventional oral anticoagulants: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 18:792–799.e61. DOI: 10.1016/j.cgh.2019.05.056. PMID: 31195162.

11. Lee JH, Lee YC, Jeon SW, et al. 2009; Guidelines of prevention and treatment for NSAID-related peptic ulcers. Korean J Gastroenterol. 54:309–317. DOI: 10.4166/kjg.2009.54.5.309. PMID: 19934612.

12. Cheung DY, Jung HY, Song HJ, et al. 2009; Guidelines of treatment for non-bleeding peptic ulcer disease. Korean J Gastroenterol. 54:285–297. DOI: 10.4166/kjg.2009.54.5.285. PMID: 19934610.

13. Chung IK, Lee DH, Kim HU, et al. 2009; Guidelines of treatment for bleeding peptic ulcer disease. Korean J Gastroenterol. 54:298–308. DOI: 10.4166/kjg.2009.54.5.298. PMID: 19934611.

14. Kim JH, Moon JS, Jee SR, et al. 2009; Guidelines of treatment for peptic ulcer disease in special conditions. Korean J Gastroenterol. 54:318–327. DOI: 10.4166/kjg.2009.54.5.318. PMID: 19934613.

15. Kim SG, Kim JG, Shin SK, et al. 2009; Guidelines of diagnosis for peptic ulcer disease. Korean J Gastroenterol. 54:279–284. DOI: 10.4166/kjg.2009.54.5.279. PMID: 19934609.

16. Sung JJ, Lau JY, Ching JY, et al. 2010; Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 152:1–9. DOI: 10.7326/0003-4819-152-1-201001050-00179. PMID: 19949136.

17. Acosta RD, Abraham NS, et al. ASGE Standards of Practice Committee. 2016; The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 83:3–16. DOI: 10.1016/j.gie.2015.09.035. PMID: 26621548.

18. Satoh K, Yoshino J, Akamatsu T, et al. 2016; Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 51:177–194. DOI: 10.1007/s00535-016-1166-4. PMID: 26879862.

19. Chan FKL, Goh KL, Reddy N, et al. 2018; Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut. 67:405–417. DOI: 10.1136/gutjnl-2017-315131. PMID: 29331946. PMCID: PMC5868286.

20. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. 2015; Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 47:a1–a46. DOI: 10.1055/s-0034-1393172. PMID: 26417980.

21. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. 2006; A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 27:2667–2674. DOI: 10.1093/eurheartj/ehl334. PMID: 17053008.

22. Eisenberg MJ, Richard PR, Libersan D, Filion KB. 2009; Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation. 119:1634–1642. DOI: 10.1161/CIRCULATIONAHA.108.813667. PMID: 19289638.

23. Qureshi W, Mittal C, Patsias I, et al. 2014; Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol. 113:662–668. DOI: 10.1016/j.amjcard.2013.10.044. PMID: 24355310.

24. Veitch AM, Vanbiervliet G, Gershlick AH, et al. 2016; Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut. 65:374–389. DOI: 10.1136/gutjnl-2015-311110. PMID: 26873868. PMCID: PMC4789831.